Trial · NCT05359315
Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis
NCT05359315, Unknown, SPP Pharmaclon Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis. Trials, record NCT05359315. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05359315
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis
- NCT number
- NCT05359315
- Status
- Unknown
- Enrollment
- 84 participants, estimated
- Lead sponsor
- SPP Pharmaclon Ltd.
- Conditions
- Pulmonary Tuberculosis
- Interventions
- Interferon-Gamma
- First posted
- 2022-05-03
- Last updated
- 2022-06-01
Source ClinicalTrials.gov
Registered outcomes34
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Sputum smear conversion according to microscopy. | 1 months | Sputum smear conversion according to microscopy. Percentage of patients. |
| Primary | Sputum smear conversion according to microscopy. | 1 months | Sputum smear conversion according to microscopy. Mean time to clinical response. |
| Primary | Sputum smear conversion according to microscopy. | 2 months | Sputum smear conversion according to microscopy. Percentage of patients. |
| Primary | Sputum smear conversion according to microscopy. | 2 months | Sputum smear conversion according to microscopy. Mean time to clinical response. |
| Primary | Sputum smear conversion according to microscopy. | 3 months | Sputum smear conversion according to microscopy. Percentage of patients. |
| Primary | Sputum smear conversion according to microscopy. | 3 months | Sputum smear conversion according to microscopy. Mean time to clinical response. |
| Primary | Sputum smear conversion according to microscopy. | 4 months | Sputum smear conversion according to microscopy. Percentage of patients. |
| Primary | Sputum smear conversion according to microscopy. | 4 months | Sputum smear conversion according to microscopy. Mean time to clinical response. |
| Primary | Sputum smear conversion according to microscopy. | 5 months | Sputum smear conversion according to microscopy. Percentage of patients. |
| Primary | Sputum smear conversion according to microscopy. | 5 months | Sputum smear conversion according to microscopy. Mean time to clinical response. |
1 to 10 of 34Source ClinicalTrials.gov
See all 34 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05359315
GET https://conductscience.org/api/trials/v1/NCT05359315/registered?page=2